Press releases
- Newly Published Results Reveal a Significant Proportion of Early-Stage HR+ Breast Cancer Survivors May Be Over- or Undertreated Without Breast Cancer Index Genomic Testing
- Hologic to Unveil Groundbreaking AI Research at ECR 2024
- Hologic to Webcast Presentations at Upcoming Investor Conferences
- Hologic Announces First and Only FDA-Cleared Digital Cytology System – Genius™ Digital Diagnostics System
- Hologic Announces Financial Results for First Quarter of Fiscal 2024
- Women's Health Remains in Crisis Worldwide Even as COVID-19 Pandemic Wanes
- Hologic Launches ‘Better Is Possible’ Health Awareness Campaign for Women
- Hologic Announces Preliminary Revenue Results for First Quarter of Fiscal 2024
- Hologic to Announce Financial Results for the First Quarter of Fiscal 2024 on Thursday, February 1, 2024
- Hologic to Webcast Presentation at the 42nd Annual J.P. Morgan Healthcare Conference
More ▼
Key statistics
On Thursday, Hologic Inc (HO1:DUS) closed at 71.98, -8.79% below its 52-week high of 78.92, set on May 02, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 71.20 |
---|---|
High | 71.98 |
Low | 71.20 |
Bid | -- |
Offer | -- |
Previous close | 71.14 |
Average volume | 21.50 |
---|---|
Shares outstanding | 234.73m |
Free float | 232.97m |
P/E (TTM) | 37.06 |
Market cap | 18.30bn USD |
EPS (TTM) | 2.10 USD |
Data delayed at least 15 minutes, as of Mar 28 2024 18:30 BST.
More ▼